[Federal Register Volume 79, Number 97 (Tuesday, May 20, 2014)]
[Notices]
[Page 28987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-11739]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Fusion Pharm, Inc.; Order of Suspension of Trading

May 16, 2014.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
FusionPharm, Inc. (``FusionPharm'') because of questions regarding the 
accuracy of assertions by FusionPharm and by others, in filings and 
disclosures made by FusionPharm on OTC Link (previously ``Pink 
Sheets'') operated by OTC Markets Group. Inc. and press releases to 
investors concerning, among other things: (1) The company's assets; (2) 
the company's revenues; (3) the company's financial statements; (4) the 
company's business transactions; and (5) the company's current 
financial condition.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above-listed 
company is suspended from the period 9:30 a.m. EDT, on May 16, 2014, 
through 11:59 p.m. EDT, on May 30, 2014.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2014-11739 Filed 5-16-14; 11:15 am]
BILLING CODE 8011-01-P